Immunopathogenesis of sarcoidosis.
The immunopathogenesis of sarcoidosis has been difficult to charaterize given the heterogeneity of disease, the elusiveness of the causative antigen, and the lack of an adequate animal model. However, by examining well-defined clinical cohorts, the interplay between genetic predisposition and immunologic response has been increasingly informative. Technological advances in cellular analysis have allowed researchers to characterize the immune responses important in the maintenance of granulomatous inflammation. Finally, "new" clinical observations such as granuloma responsiveness to targeted biological therapies, sarcoid developing during immune restoration, and the relationship between sarcoidosis and Hepatitis C will provide future insight to the immunopathogenesis of sarcoidosis.
Noor
Aliya
A
Division of Pulmonary and Critical Care Medicine, Indiana University and the Richard L. Roudebush VA Medical Center, Indianapolis, IN.
Knox
Kenneth S
KS
D003713:Dendritic Cells / Q000276:immunology; D006099:Granuloma / Q000276:immunology / Q000473:pathology; D006801:Humans; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D012507:Sarcoidosis / Q000276:immunology* / Q000473:pathology*; D017565:Sarcoidosis, Pulmonary / Q000276:immunology / Q000473:pathology; D012871:Skin Diseases / Q000276:immunology* / Q000473:pathology*; D050378:T-Lymphocytes, Regulatory / Q000276:immunology